NaCl 0.9%: Clinical Trials

100 trials of NaCl 0.9%, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

63 completed, 18 unknown, 12 terminated, 2 active not recruiting. 30 Phase 2, 29 Phase 4, 26 Phase 3, 15 Not applicable, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 230Completed 18, Terminated 6, Unknown 5, Active not recruiting 1
Phase 429Completed 21, Unknown 5, Withdrawn 2, Terminated 1
Phase 326Completed 15, Unknown 6, Terminated 3, Not yet recruiting 1, Recruiting 1
Not applicable15Completed 9, Unknown 3, Terminated 2, Active not recruiting 1
Phase 111Completed 8, Terminated 2, Unknown 1
Early Phase 11Recruiting 1

Follow NaCl 0.9%: new trials by email Literature Review of NaCl 0.9% trials Research Report on NaCl 0.9%

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery
Tranexamic Acid (Topical), Normal Saline (Placebo) - Cesarean Delivery, Postpartum Hemorrhage (PPH)
Early Phase 1RecruitingWolfson Medical Center1122026-07-012026-07-02
Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty
NaCl 0.9%, Dexamethasone 4mg - Osteoarthritis, Knee, Knee Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences902025-09-132026-05-22
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
Dexamethasone, Tocilizumab, Anakinra - Sepsis, Neuroinflammatory Response
Phase 4UnknownRadboud University Medical Center522024-10-242025-04-04
Tranexamic Acid in Vaginal Reconstructive Surgery
Tranexamic acid, Vasopressin, NaCl 0.9% - Pelvic Organ Prolapse
Phase 4WithdrawnThe University of Texas Medical Branch, Galveston2024-07-012025-01-31
Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty (NEFARTHRO)
Nefopam, NaCl 0.9% - Total Hip Arthroplasty
Phase 3Not yet recruitingUniversity Hospital, Tours5462024-04-012024-04-05
Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty
Remimazolam 20 MG Injection [Byfavo], NaCl 0.9% - Remimazolam, Emergence Delirium
Phase 2UnknownUniversity Hospital of Split802024-03-062024-05-03
Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery
Meloxicam Injection 30mg, Meloxicam Injection 60mg, Nacl 0.9% - Pain, Post-operative
Phase 2UnknownBeijing Tide Pharmaceutical Co., Ltd1082023-07-012023-07-18
Effect of Hot Saline Irrigation on the Operative Field During Endoscopic Sinus Surgery
Normal saline heated up to 50 °C - Rhinosinusitis
Not applicableCompletedRawalpindi Medical College602023-06-162024-04-02
Effectiveness of Continous Adjuvant Lidocaine on General Anaesthesia on Tumor Craniotomy Surgery
NaCl 0.9%, Adjuvant lidocaine continous - Surgery, Anesthesia; Functional
Not applicableCompletedUniversitas Indonesia602023-01-162024-02-16
SAINT: Safe Induction of Labor Trial
Buscopan 20 MG/ML Injectable Solution, Sodium bicarbonate, Placebo - Labor Complication, Induced; Birth
Phase 3RecruitingOslo University Hospital30002023-01-032024-04-04
The Impact of a Single Dexmedetomidine Bolus on Intraoperative Sevoflurane Consumption (DEXHALE)
Dexmedetomidine, Placebo - Inhalation Anesthesia, Dexmedetomidine
Not applicableTerminatedCiusss de L'Est de l'Île de Montréal482022-12-052026-10-23
5-HT3 Receptor Antagonist and Respiratory Drive in Patients With ARDS
Placebo, Ondansetron - Acute Respiratory Distress Syndrome
Phase 4UnknownCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal102022-11-102023-09-28
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
Dexmedetomidine Hcl 100 Mcg/mL Inj, Placebo - Congenital Heart Disease in Children, Cardiopulmonary Bypass
Phase 2 / Phase 3CompletedNational Cardiovascular Center Harapan Kita Hospital Indonesia662022-10-102023-08-24
Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.
Antioxidant therapy, NaCl 0.9% - Acute Myocardial Infarction, Ischemia-reperfusion Injury
Phase 1CompletedUniversity of Chile182022-08-092024-01-12
Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery
Ropivacaine Hydrochloride Injection, Sodium chloride - Spondylolisthesis, Lumbar Disc Herniation
Phase 4CompletedIlse van de Wijgert762022-06-012024-04-17
Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
Tocilizumab, Dobutamine, NaCl 0.9% - Acute Myocardial Infarction, Cardiogenic Shock
Phase 2Active not recruitingCopenhagen University Hospital, Rigshospitalet1002022-03-132025-07-17
CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients
Methylprednisolone, NaCl 0.9% - Inflammatory Response, Weakness, Muscle
Phase 4CompletedZiekenhuis Oost-Limburg7512022-02-162026-01-27
Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain.
Morphine, Nacl 0.9% - Pain, Postoperative, Anesthesia
Not applicableActive not recruitingTel-Aviv Sourasky Medical Center1152022-02-162024-11-20
The Effects of Intra-articular Platelet-Rich Plasma Injection on The Severity of Knee Osteoarthritis
PRP, Normal Saline - Osteoarthritis, Knee
Not applicableCompletedUniversitas Bali Internasional1062022-01-012023-02-10
Study of Postoperative ICC Analgesia
Ropivacain, NaCl 0.9% - Postoperative Analgesia
Phase 3CompletedUniversity Hospital, Basel, Switzerland322021-12-152023-10-24

Showing 20 of 100. Sign in to see all of them.

Conditions studied

Pain, Postoperative (7)  ·  Pain (5)  ·  Agnosia (4)  ·  Inflammation (4)  ·  Postoperative Nausea and Vomiting (4)  ·  Sepsis (4)  ·  COVID-19 (3)  ·  Dengue (3)  ·  Premature Birth (3)  ·  Severe Dengue (3)  ·  Anemia, Iron-Deficiency (2)  ·  Blood Loss, Surgical (2)  ·  Cerebral Palsy (2)  ·  Cicatrix (2)  ·  Coronary Artery Disease (2)

Sponsors

Assistance Publique - Hôpitaux de Paris (3)  ·  National Cardiovascular Center Harapan Kita Hospital Indonesia (3)  ·  Sanofi Pasteur, a Sanofi Company (3)  ·  University Hospital, Basel, Switzerland (3)  ·  University Hospital, Grenoble (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Balgrist University Hospital (2)  ·  Guerbet (2)  ·  Insel Gruppe AG, University Hospital Bern (2)  ·  Nantes University Hospital (2)  ·  Oslo University Hospital (2)  ·  University of Liege (2)  ·  Ahmad Jabir Rahyussalim (1)  ·  Ascension Health (1)  ·  Atox Bio Ltd (1)

Countries

France (14)  ·  Switzerland (13)  ·  Belgium (10)  ·  Germany (9)  ·  United States (8)  ·  Indonesia (6)  ·  Netherlands (6)  ·  Israel (5)  ·  Canada (3)  ·  China (3)  ·  Denmark (3)  ·  Finland (3)  ·  Italy (3)  ·  Norway (3)  ·  Austria (2)

Top investigators

Patrick Zingg, MD (2)  ·  A. H. Epema, dr, MD (1)  ·  Abraham IJ Gajardo, MD, PhD (1)  ·  Alexander Wilmer, MD, PhD (1)  ·  Aljaz Hojski, Dr. med. (1)  ·  Amichai Rottenstreich (1)  ·  Amie Jones, MD (1)  ·  Aml M Aljaml (1)  ·  Anders Opdahl, MD, PhD (1)  ·  Ann Tran, MD (1)  ·  Antonio Abbate, M.D., Ph.D. (1)

Results publications

PMID 25157725, PMID 25534356, PMID 27187300, PMID 29515037, PMID 12519925, PMID 14578723, PMID 17063747, PMID 17197840, PMID 18648227, PMID 18676556, PMID 19287090, PMID 19301059, PMID 19424209, PMID 20421357, PMID 21153402, PMID 21186139, PMID 21508983, PMID 22187279, PMID 22383042, PMID 22693226, PMID 22776958, PMID 22894958, PMID 22939099, PMID 23400744, PMID 23427891, PMID 23453459, PMID 23635914, PMID 23839107, PMID 23842591, PMID 23937996, PMID 23966238, PMID 24015953, PMID 24189367, PMID 24232462, PMID 24467979, PMID 24634631, PMID 24862623, PMID 24969309, PMID 25121719, PMID 25158709, PMID 25169040, PMID 25482680, PMID 25541942, PMID 25563879, PMID 25863661, PMID 26066773, PMID 26914224, PMID 27130143, PMID 27244862, PMID 27282374

NIH funding

2004 (2), 2009 (2), 2014 (2), 2017 (2), 2016 (1), 2018 (1), 2019 (1), 2023 (1), R01DK101984 (1)